1. APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients

   • Jia-Horng Kao
   • Wen-Juei Jeng
   • Man-Fung Yuen

   Guidelines 23 July 2021 Pages: 833 - 851

   

2. Prognosis prediction or treatment allocation?

   • Ryosuke Tateishi

   Editorial 09 May 2021 Pages: 852 - 854

3. Biomarkers of endothelial dysfunction in alcoholic hepatitis

   • Tiffany Wu
   • Vijay Shah

   Editorial 27 May 2021 Pages: 855 - 857

4. A step forward in the choice of fluid for early resuscitation of critically ill patients with cirrhosis

   • Paolo Angeli

   Editorial 07 July 2021 Pages: 858 - 859

5. The clinical and economic burden of non-alcoholic steatohepatitis in the Middle East: behind the scene

   • Lung-Yi Mak
   • James Fung

   Editorial 18 June 2021 Pages: 860 - 862

   

6. Primary prophylaxis of gastric variceal bleeding: the choices need to be tested!!

   • Chitranshu Vashishtha
   • Shiv Kumar Sarin

   Editorial 10 August 2021 Pages: 863 - 867

   

7. The overview of the deep learning integrated into the medical imaging of liver: a review

   • Kailai Xiang
   • Baihui Jiang
   • Dong Shang

   Review Article 15 July 2021 Pages: 868 - 880

   

8. Statins associate with better clinical outcomes in chronic hepatitis B patients with HBsAg seroclearance

   • Ka Shing Cheung
   • Lung Yi Mak
   • Man Fung Yuen

   Original Article 14 May 2021 Pages: 881 - 891

   

9. Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy

   • Joo Hyun Oh
   • Hye Won Lee
   • Yong-Han Paik

   Original Article 14 July 2021 Pages: 892 - 900

   

10. Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection

    • Lung-Yi Mak
    • Rex Wan-Hin Hui
    • Wai-Kay Seto

    Original Article 21 June 2021 Pages: 901 - 911

    

11. Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait

    • Faisal M. Sanai
    • Abdullah Al Khathlan
    • Ahmed Al-jedai

    Original Article Open access 06 April 2021 Pages: 912 - 921

    

12. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease

    • Rafael Paternostro
    • Katharina Staufer
    • Michael Trauner

    Original Article Open access 02 June 2021 Pages: 922 - 933

    

13. Primary prophylaxis of gastric variceal bleeding: endoscopic obturation, radiologic intervention, or observation?

    • Jung Wan Choe
    • Hyung Joon Yim
    • Soon Ho Um

    Original Article 11 March 2021 Pages: 934 - 945

    

14. Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma

    • Chih-Wen Lin
    • Yaw-Sen Chen
    • Ming-Lung Yu

    Original Article 18 May 2021 Pages: 946 - 956

    

15. Hepatocyte-derived exosome may be as a biomarker of liver regeneration and prognostic valuation in patients with acute-on-chronic liver failure

    • Yan Jiao
    • Wang Lu
    • Yingmin Ma

    Original Article 07 July 2021 Pages: 957 - 969

    

16. Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure

    • Nipun Verma
    • Radha Krishan Dhiman
    • APASL ACLF Research Consortium (AARC) for APASL ACLF working Party

    Original Article 18 July 2021 Pages: 970 - 982

    

17. Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial

    • Cyriac Abby Philips
    • Rakhi Maiwall
    • Shiv Kumar Sarin

    Original Article 25 May 2021 Pages: 983 - 994

    

18. A novel radiomics–platelet nomogram for the prediction of gastroesophageal varices needing treatment in cirrhotic patients

    • Yiken Lin
    • Lijuan Li
    • Yanjing Gao

    Original Article 11 June 2021 Pages: 995 - 1005

    

19. Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis

    • Delia Blaya
    • Teresa Rubio-Tomás
    • Pau Sancho-Bru

    Original Article 05 May 2021 Pages: 1006 - 1017

    

20. Longitudinal progression of clinical variables associated with graded liver injury in COVID-19 patients

    • Justin Y. Lu
    • Harnadar Anand
    • Tim Q. Duong

    Original Article 15 July 2021 Pages: 1018 - 1026

    

21. Prediction of post TIPS hepatic encephalopathy: are we there yet?

    • Sanchit Sharma
    • Ashish Chauhan
    • Anoop Saraya

    Letter to the Editor 11 June 2021 Pages: 1027 - 1027

22. Evidence of nucleos(t)ide analogue (NUC) therapy in HBV DNA negative decompensated cirrhosis

    • Shahinul Alam
    • Md. Abdullah Saeed Khan
    • Mobin Khan

    Letter to the Editor 16 July 2021 Pages: 1028 - 1029